Use of avexitide in patients with post-bariatric hypoglycaemia and hyperinsulinemic hypoglycaemia
Phase 2b results of avexitide (Eiger BioPharmaceuticals) in patients with post-bariatric hypoglycemia (PBH) and hyperinsulinemic...
Use of avexitide in patients with post-bariatric hypoglycaemia and hyperinsulinemic hypoglycaemia
10% weight loss with anti-obesity drugs and lifestyle changes
Standardise language and terminology in scientific journals and with patients
Weight bias pervasive across racial and ethnic groups
Outdated guidelines preventing patients with class I obesity from accessing bariatric surgery
No clinical benefit for insurance-mandated weight management programme pre-bariatric surgery
Journal Watch 08/06/2022